Physician profile
John D Applegate
NPI 1427056597
$982.73
in general payments reported to CMS, 2019-2025
15 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $140 · 2021: $177 · 2022: $64.51 · 2023: $113 · 2024: $172 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $299.08 | 2019-2025 | Pediarix, Bexsero, Rotarix |
| Ironshore Pharmaceuticals INC. | $181.75 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $82.04 | 2020-2022 | |
| Corium, LLC | $76.94 | 2023-2025 | Azstarys |
| Pfizer INC. | $70.98 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $45.95 | 2021-2023 | Vaxneuvance, M-M-R II, Gardasil 9 |
| Collegium Pharmaceutical, INC. | $42.86 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $39.87 | 2019-2025 | |
| Tris Pharma INC | $31.70 | 2019-2021 | |
| Neurelis, INC. | $26.88 | 2020 | |
| Abbvie INC. | $20.32 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.91 | 2024 | |
| Cranial Technologies, INC | $16.92 | 2025 | Doc Band |
| Alexion Pharmaceuticals, INC. | $15.09 | 2020 | |
| Shire North American Group INC | $14.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Applegate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.